Companies Mentioned
Astellas Pharma, Inc.
Category
Title
Summary
Date
Commentaries
Patent Law
Patent Law
The Federal Circuit has resolved prior inconsistencies in its case law and established a bright line rule to define infringement in product-by-process claims, holding that such infringement requires practice of the claimed process by the alleged infringer. In Abbott Labs v. Sandoz, 566 F.3d 1282 (Fed. Cir. 2009), the Federal…
Posted:
07/13/2009
07/13/2009
LawLoop Demo
Welcome to the Future